HSY
54
-3
VRTX
73
2
ABT
47
-3
FLR
55
6
INTC
31
2
RIG
44
-3
VRSK
80
5
T
59
12
ORCL
65
7
UA
32
-12
URI
58
2
VRSN
49
-3
CRM
44
-6
JNPR
43
2
DVA
73
6
AFL
63
3
DE
32
9
M
52
2
TXN
52
13
GME
65
2
HSY
54
-3
VRTX
73
2
ABT
47
-3
FLR
55
6
INTC
31
2
RIG
44
-3
VRSK
80
5
T
59
12
ORCL
65
7
UA
32
-12
URI
58
2
VRSN
49
-3
CRM
44
-6
JNPR
43
2
DVA
73
6
AFL
63
3
DE
32
9
M
52
2
TXN
52
13
GME
65
2
Financhill
Back

KalVista Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Sell
50

KALV
KalVista Pharmaceuticals

Last Price:
11.30
Seasonality Move:
4.45%
Sell
48

CATX
Perspective Therapeutics

Last Price:
1.50
Seasonality Move:
17.15%
Sell
50
KalVista Pharmaceuticals (KALV) is a Sell

Is KalVista Pharmaceuticals a Buy, Sell or Hold?

  • The current KalVista Pharmaceuticals [KALV] share price is $11.30. The Score for KALV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • KALV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $1.50. The Score for CATX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KALV Stock Price Chart

What is KalVista Pharmaceuticals's stock price today?

  • The KalVista Pharmaceuticals share price today is $11.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $1.50
    The current trend is moderately bearish and CATX is experiencing slight selling pressure.

KALV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 40.96 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.12 - 12.24) Sell
Bollinger Bands (100): (11.3 - 14.02) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 43.11 Sell
Chaikin Money Flow: -3229717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.55 - 1.77) Sell
Bollinger Bands (100): (0.74 - 1.56) Buy

KALV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.72 Sell
20-day SMA: 11.88 Sell
50-day SMA: 11.65 Sell
200-day SMA: 11.13 Buy
8-day EMA: 11.64 Sell
20-day EMA: 11.75 Sell
50-day EMA: 11.9 Sell
200-day EMA: 11.34 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.55 Sell
20-day SMA: 1.67 Sell
50-day SMA: 1.51 Sell
200-day SMA: 0.73 Buy
8-day EMA: 1.57 Sell
20-day EMA: 1.61 Sell
50-day EMA: 1.48 Buy
200-day EMA: 0.94 Buy

KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.40 per share, and an increase next year of $0.62 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

KalVista Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):